Delivery Order SPE2DB22D1200-SPE2DB25FN2DA
Award Date
5/22/25
Potential Completion Date
5/23/25
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier, to provide FEBUXOSTAT 40 MG TABLET 30S. The fixed-price contract has a ceiling value of $1,138.50 and an ultimate completion date of July 8, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of febuxostat 40 mg tablets. The contract has a firm fixed price, with a ceiling value of $1,273.48, and a period of performance ending on June 23, 2025. The contract is not set aside and was awarded on June 20, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,139.81, is for the delivery of FEBUXOSTAT 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,064.52 firm fixed-price delivery order is for the supply of 4567557705 ! FEBUXOSTAT 40 MG TABLET 30S. The contract has an ultimate completion date of March 13, 2025 and was awarded on March 12, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply 4,566,025 units of the drug febuxostat 40 mg tablets. The delivery order contract, valued at $1,624.68, has a firm fixed price and an ultimate completion date of October 7, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through...
The U.S. Defense Logistics Agency (DLA) awarded a $1,518.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,497,445 units of Febuxostat 40 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
This is a $1,460.47 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of 4568275407 - FEBUXOSTAT 40 MG TABLET 30S. The delivery order has an ultimate completion date of May 19, 2025 and is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FEBUXOSTAT 40 MG TABLET 30S. The contract has a ceiling value of $5,005.81 and is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,066.78, is for the delivery of 4564792753 FEBUXOSTAT 40 MG TABLET 30S. This is a firm fixed price delivery order contract with a completion date of June 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
The federal contract award, issued by the Defense Logistics Agency (DLA) Troop Support Medical, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,307.73, is a Firm Fixed Price Delivery Order for the supply of FEBUXOSTAT 40 MG TABLET 30S, a medication used to treat gout. The contract has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...